Literature DB >> 16776017

The costs of caring: Who pays? Who profits? Who panders?

Leonard M Fleck1.   

Abstract

Keywords:  Health Care and Public Health

Mesh:

Substances:

Year:  2006        PMID: 16776017     DOI: 10.1353/hcr.2006.0040

Source DB:  PubMed          Journal:  Hastings Cent Rep        ISSN: 0093-0334            Impact factor:   2.683


× No keyword cloud information.
  12 in total

1.  The Ethics of Chronic Dialysis for the Older Patient: Time to Reevaluate the Norms.

Authors:  Bjorg Thorsteinsdottir; Keith M Swetz; Robert C Albright
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-14       Impact factor: 8.237

2.  The Evolving Ethics of Dialysis in the United States: A Principlist Bioethics Approach.

Authors:  Catherine R Butler; Rajnish Mehrotra; Mark R Tonelli; Daniel Y Lam
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-11       Impact factor: 8.237

Review 3.  Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities.

Authors:  Zhiliang Cheng; Ajlan Al Zaki; James Z Hui; Vladimir R Muzykantov; Andrew Tsourkas
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

4.  Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco.

Authors:  Saber Boutayeb; Abdesslam Boutayeb; Naoual Ahbeddou; Wiam Boutayeb; Essaadi Ismail; Mehdi Tazi; Hassan Errihani
Journal:  Cost Eff Resour Alloc       Date:  2010-09-10

Review 5.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Authors:  Nicole M Davis; Melissa Sokolosky; Kristin Stadelman; Steve L Abrams; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Jerry Polesel; Roberta Maestro; Antonino D'Assoro; Lyudmyla Drobot; Dariusz Rakus; Agnieszka Gizak; Piotr Laidler; Joanna Dulińska-Litewka; Joerg Basecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Giuseppe Montalto; Melchiorre Cervello; Timothy L Fitzgerald; Zoya Demidenko; Alberto M Martelli; Lucio Cocco; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2014-07-15

6.  Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.

Authors:  Yunfeng Ma; Dong Xiang; Jinwen Sun; Chuanlin Ding; Min Liu; Xiaoling Hu; Guoxin Li; Goetz Kloecker; Huang-Ge Zhang; Jun Yan
Journal:  J Immunol       Date:  2013-04-29       Impact factor: 5.422

7.  The economic pressures for biosimilar drug use in cancer medicine.

Authors:  Paul Cornes
Journal:  Target Oncol       Date:  2012-01-17       Impact factor: 4.493

8.  Inherently stealthy and highly tumor-selective gold nanoraspberries for photothermal cancer therapy.

Authors:  Naveen Gandra; Christopher Portz; Saide Z Nergiz; Andrew Fales; Tuan Vo-Dinh; Srikanth Singamaneni
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

9.  Cost-effectiveness analysis of trastuzumab in the adjuvant treatment for early breast cancer.

Authors:  Ali Aboutorabi; Mohammad Hadian; Hossein Ghaderi; Masoud Salehi; Maryam Ghiasipour
Journal:  Glob J Health Sci       Date:  2014-08-14

Review 10.  Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems.

Authors:  Jihye Yoo; Changhee Park; Gawon Yi; Donghyun Lee; Heebeom Koo
Journal:  Cancers (Basel)       Date:  2019-05-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.